Celestica (NYSE:CLS) Trading 8.1% Higher – Here’s What Happened

Celestica, Inc. (NYSE:CLSGet Free Report) (TSE:CLS) was up 8.1% during mid-day trading on Tuesday . The stock traded as high as $329.84 and last traded at $333.2920. Approximately 917,682 shares changed hands during trading, a decline of 63% from the average daily volume of 2,474,284 shares. The stock had previously closed at $308.25.

Trending Headlines about Celestica

Here are the key news stories impacting Celestica this week:

  • Positive Sentiment: Q4 beat and raised outlook: Celestica reported stronger-than-expected Q4 revenue and EPS (revenue up ~44%, EPS above estimates) and raised its FY‑2026 revenue and EPS guidance, supporting a bullish longer‑term growth story. Read More.
  • Positive Sentiment: Analyst support: Bank of America initiated coverage with a Buy and a $400 target; RBC reiterated Buy — these carry weight for investor confidence despite near‑term volatility. Read More.
  • Neutral Sentiment: Updated guidance details: Management gave Q1 EPS and revenue ranges above consensus and set FY‑2026 revenue target at $17B, reinforcing the company’s demand outlook but raising expectations for execution. Read More.
  • Negative Sentiment: Accelerated $1B CapEx for AI: Management said it is accelerating ~$1 billion of capital expenditures to expand capacity for AI/data‑center demand — a near‑term cash and execution risk that likely worried investors despite the revenue upside. Read More.
  • Negative Sentiment: Spending plan reaction and sell‑off: News that Celestica boosted its spending plan triggered an outsized intraday sell‑off as some investors appear to prefer near‑term cash conservatism over aggressive capacity build. Read More.
  • Negative Sentiment: Investor litigation probe: A law firm announced an investor investigation into Celestica, adding regulatory/legal uncertainty that can amplify volatility. Read More.

Wall Street Analyst Weigh In

CLS has been the subject of a number of research analyst reports. Barclays boosted their target price on shares of Celestica from $357.00 to $359.00 and gave the stock an “overweight” rating in a research report on Friday, November 14th. Stifel Nicolaus restated a “buy” rating and set a $385.00 target price (up previously from $230.00) on shares of Celestica in a research note on Wednesday, October 29th. UBS Group lifted their price target on Celestica from $208.00 to $350.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 29th. TD Cowen reiterated a “hold” rating and set a $238.00 price target on shares of Celestica in a report on Friday, October 3rd. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $400.00 price objective on shares of Celestica in a research note on Thursday, January 22nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $344.24.

Get Our Latest Research Report on Celestica

Celestica Stock Performance

The company has a quick ratio of 0.88, a current ratio of 1.47 and a debt-to-equity ratio of 0.37. The firm has a 50-day moving average of $311.10 and a 200 day moving average of $265.75. The stock has a market capitalization of $34.41 billion, a P/E ratio of 41.66 and a beta of 1.87.

Celestica (NYSE:CLSGet Free Report) (TSE:CLS) last announced its quarterly earnings data on Monday, October 27th. The technology company reported $1.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.45 by $0.13. Celestica had a net margin of 6.72% and a return on equity of 35.87%. The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.01 billion. During the same quarter in the prior year, the company posted $1.04 EPS. The business’s revenue was up 27.8% on a year-over-year basis. Research analysts anticipate that Celestica, Inc. will post 4.35 EPS for the current fiscal year.

Institutional Investors Weigh In On Celestica

Large investors have recently modified their holdings of the stock. Arrowstreet Capital Limited Partnership boosted its stake in Celestica by 471.5% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 3,146,928 shares of the technology company’s stock valued at $775,133,000 after buying an additional 2,596,318 shares in the last quarter. Viking Global Investors LP bought a new position in shares of Celestica during the third quarter valued at $424,459,000. Norges Bank acquired a new stake in shares of Celestica in the 2nd quarter valued at $236,069,000. SRS Investment Management LLC bought a new stake in shares of Celestica in the 2nd quarter worth about $135,289,000. Finally, Picton Mahoney Asset Management acquired a new stake in shares of Celestica during the 2nd quarter worth about $90,425,000. 67.38% of the stock is currently owned by institutional investors.

About Celestica

(Get Free Report)

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

Read More

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.